Neuproscan

Free

Detect Alzheimer's years in advance with NeuProScan's advanced AI platform

HealthcareFree

#AI#Medical#Alzheimer's#Diagnosis#MRI#PET#Scans#Custom AI Models#Cloud#On-device

Type

Saas

Visit Website

About Neuproscan

NeuProScan is an AI platform designed to predict the likelihood of developing Alzheimer's disease years in advance using a single MRI scan. It helps doctors improve MRI diagnosis accuracy by reducing the high false positive (29%) and false negative (27%) rates associated with standard MRI interpretation. The tool automatically selects up to nine impactful MRI slices from axial, coronal, and sagittal views to make its prediction. NeuProScan has correctly identified 88% of patients who later developed Alzheimer's as very likely to develop the disease. It supports both on-device and cloud operations, allows users to create custom AI models, and is intended for research purposes only—not for clinical diagnosis. By improving the efficiency of PET scan referrals, NeuProScan helps healthcare systems manage resources more effectively, while giving patients and families time to plan and participate in clinical trials.

Key Features

AI-driven predictions

Single MRI scan analysis

Customizable AI models

On-device and cloud operations

Impactful MRI slice selection

High diagnostic accuracy

Supports research purposes

Beneficial for doctors and hospitals

Optimizes costly PET scans

User-friendly interface

Pros & Cons

Pros

Early detection years before symptoms appear, allowing time for planning and clinical trial enrollment
Uses affordable MRI scans ($1300) instead of expensive PET scans ($5000)
High accuracy: correctly identified 88% of future Alzheimer's patients
Customizable AI models and flexible deployment (on-device or cloud)
Helps reduce unnecessary PET scans, saving healthcare costs
User-friendly interface suitable for both individual doctors and large hospitals

Cons

Not intended for medical diagnosis; provided for research purposes only
Requires MRI scan, which may not be accessible in all regions
Limited to pre-clinical Alzheimer's detection; may not cover other dementia types
Accuracy depends on quality of MRI scan and slice selection

Best For

Doctors: Improving diagnostic accuracy for early Alzheimer’s by selecting impactful MRI slices.Hospitals: Optimizing the use of costly PET scans and enhancing patient care with accurate predictions.Researchers: Using an advanced AI tool for conducting Alzheimer's disease research.Patients and families: Planning for the future by getting early predictions of Alzheimer’s likelihood.Clinical Trial Managers: Identifying eligible patients earlier for participation in clinical trials.Healthcare Administrators: Managing resources effectively by reducing the demand on expensive diagnostic procedures.Tech-Savvy Doctors: Creating custom AI models tailored to specific diagnostic needs.Public Health Officials: Monitoring and planning for Alzheimer's disease trends on a larger scale.Medical Educators: Training new doctors on advanced diagnostic tools and early detection methods.Medical Device Manufacturers: Incorporating advanced AI predictions into next-gen MRI scan equipment.